| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/11/2013 | WO2013050438A1 Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases. |
| 04/11/2013 | WO2013050421A1 Herbicidal pyridazinone derivatives |
| 04/11/2013 | WO2013026866A3 Pyridine-, pyrazine-, triazine- and tetrazine-derived microbiocides |
| 04/11/2013 | WO2012170976A3 Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity |
| 04/11/2013 | WO2012158843A3 Kinase inhibitors |
| 04/11/2013 | US20130090358 Pyrazolylaminopyridine derivatives useful as kinase inhibitors |
| 04/11/2013 | US20130090352 Tetrahydroquinoline amide m1 receptor positive allosteric modulators |
| 04/11/2013 | US20130090342 Biphenyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives |
| 04/11/2013 | US20130090341 Heterocyclic compounds |
| 04/11/2013 | US20130090338 New ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments |
| 04/11/2013 | US20130090332 Ethynyl derivatives |
| 04/11/2013 | US20130090324 Novel prolylcarboxypeptidase inhibitors |
| 04/11/2013 | US20130089520 Macrocyclic Inhibitors Of Hepatitis C Virus |
| 04/11/2013 | US20130087771 Organic materials and organic electroluminescent apparatuses using the same |
| 04/11/2013 | US20130087768 Heterocyclic compound, organic light-emitting diode comprising the heterocyclic compound, and flat panel display device comprising the organic light-emitting diode |
| 04/11/2013 | CA2851405A1 Carbamate/ urea derivatives containing piperidin and piperazin rings as h3 receptor inhibitors |
| 04/11/2013 | CA2851082A1 1,3-substituted azetidine pde10 inhibitors |
| 04/11/2013 | CA2851037A1 Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases |
| 04/11/2013 | CA2850082A1 Ethynyl derivatives as mglur5 allosteric modulators |
| 04/11/2013 | CA2850055A1 Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)-prop-2-en-1-one hydrochloride and intermediates used therein |
| 04/11/2013 | CA2850013A1 Herbicidal pyridazinone derivatives |
| 04/11/2013 | CA2842881A1 Cysteinyl leukotriene antagonists |
| 04/10/2013 | EP2578580A1 G, I and K crystal forms of imatinib mesylate |
| 04/10/2013 | EP2578573A1 Fused imidazole derivative |
| 04/10/2013 | EP2578572A1 Compounds with acridan ring structures and organic electroluminescence elements |
| 04/10/2013 | EP2578571A1 Isoquinoline modulators of ATP-binding cassette transporters |
| 04/10/2013 | EP2578569A1 Heterocyclic ring compound and h1 receptor antagonist |
| 04/10/2013 | EP2576543A1 Pyrazole compounds as sigma receptor inhibitors |
| 04/10/2013 | EP2576540A2 Heteroaryl compounds and methods of use thereof |
| 04/10/2013 | EP2576539A1 Pyridinylcarboxylic acid derivatives as fungicides |
| 04/10/2013 | EP2576538A1 New ccr2 antagonists |
| 04/10/2013 | EP2576537A1 2 -amino- pyrimidine derivatives useful as inhibitors of jnk |
| 04/10/2013 | EP2576520A1 Radiolabeled compounds and methods thereof |
| 04/10/2013 | EP2576516A1 N-[(het)arylethyl)]pyrazole(thio)carboxamides and their heterosubstituted analogues |
| 04/10/2013 | EP2576510A1 Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer |
| 04/10/2013 | EP2576509A1 Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies |
| 04/10/2013 | EP2576507A1 Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application |
| 04/10/2013 | EP2575968A1 Compounds for the treatment of clostridium difficile associated disease |
| 04/10/2013 | EP2575866A1 Inhibitors of hcv ns5a |
| 04/10/2013 | EP2356105B1 ( pyrrolidin-2 -yl) phenyl derivatives for use in the treatment of pain |
| 04/10/2013 | CN1759114B Heterocyclic N-aryl carboxamides as cytokine inhibitors |
| 04/10/2013 | CN103038229A Heteroaryl compounds and methods of use thereof |
| 04/10/2013 | CN103038227A Nilotinib salts and crystalline forms thereof |
| 04/10/2013 | CN103038218A Condensed ring pyridine compound |
| 04/10/2013 | CN103038217A Novel microbiocidal dioxime ether derivatives |
| 04/10/2013 | CN103030636A Macrocyclic inhibitors of hepatitis c virus |
| 04/10/2013 | CN103030631A Compound for preparing pyrimidinedione DPP-IV (dipeptidyl peptidase IV) inhibitors |
| 04/10/2013 | CN103030630A Organic material and organic electroluminescent device adopting organic material |
| 04/10/2013 | CN103030629A Method for preparing fasudil hydrochloride |
| 04/10/2013 | CN103030628A Dermatitis treating agent |
| 04/10/2013 | CN103030585A Heterocyclic compound, organic light-emitting diode and flat panel display device |
| 04/10/2013 | CN102336741B Fluorine-18-marked myocardial perfusion developing agent and preparation method and application thereof |
| 04/10/2013 | CN102260244B Stable rabeprazole sodium compound |
| 04/10/2013 | CN101817813B Crystal IV of 3-(substituted dihydroisoindolinone-2-yl)-2,6-piperidinediketone and medicinal composite thereof |
| 04/10/2013 | CN101723934B Method for refining fasudil hydrochloride |
| 04/10/2013 | CN101417996B Compounds with symmetric structure containing carbazole and naphthalimide groups, preparation method and use thereof |
| 04/10/2013 | CN101291925B Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists |
| 04/09/2013 | US8415484 Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders |
| 04/09/2013 | US8415482 Proline derivatives |
| 04/09/2013 | US8415478 Barium salt of benzimidazole derivative |
| 04/09/2013 | US8415469 Compounds and methods for kinase modulation, and indications therefor |
| 04/09/2013 | US8415382 Substituted benzazoles and methods of their use as inhibitors of RAF Kinase |
| 04/09/2013 | US8415380 Pyridine and pyrimidine derivatives as MGLUR2 antagonists |
| 04/09/2013 | US8415378 Isoxazol-3(2H)-one analogs as therapeutic agents |
| 04/09/2013 | US8415377 Triazole compounds that modulate HSP90 activity |
| 04/09/2013 | US8415376 Inhibitors of PI3 kinase |
| 04/09/2013 | US8415373 Isoquinolinone derivatives as NK3 antagonists |
| 04/09/2013 | US8415372 Sulfonamide compound |
| 04/09/2013 | US8415368 Acid secretion inhibitor |
| 04/09/2013 | US8415359 Phenylpyrrole derivative |
| 04/09/2013 | US8415356 Isoquinolinone derivatives as NK3 antagonists |
| 04/09/2013 | US8415354 Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 04/09/2013 | US8415350 Benzoyl-piperidine derivatives as dual modulators of the 5-HT2A and D3 receptors |
| 04/09/2013 | US8415349 Dicycloazaalkane derivatives, preparation processes and medical uses thereof |
| 04/09/2013 | US8415343 Autoimmune diseases; antiinflammatory agents; antiproliferative agents; benzodiazepine compound |
| 04/09/2013 | US8415341 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors |
| 04/09/2013 | CA2737565C N-phenyl-2-pyrimidine-amine derivatives |
| 04/09/2013 | CA2659590C Irreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 04/09/2013 | CA2588881C Potentiators of glutamate receptors |
| 04/09/2013 | CA2587642C Substituted heterocycles and methods of use |
| 04/09/2013 | CA2572833C Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| 04/09/2013 | CA2569827C Quinazolinedione derivatives as parp inhibitors |
| 04/09/2013 | CA2536436C 2-amido-4-aryloxy-1-carbonyl pyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 04/09/2013 | CA2531050C Pharmaceutical compounds |
| 04/09/2013 | CA2527192C Novel imidazole derivatives, the production thereof, and the use of the same as a medicament |
| 04/09/2013 | CA2513915C New arylpiperazinyl compounds |
| 04/04/2013 | WO2013049719A1 Compounds useful as inhibitors of atr kinase |
| 04/04/2013 | WO2013049565A1 Imidazole derivatives as cyp17 inhibitors for the treatment of cancer |
| 04/04/2013 | WO2013049559A1 Pyridine derivatives |
| 04/04/2013 | WO2013049119A1 Selective nr2b antagonists |
| 04/04/2013 | WO2013049104A1 Pyridinedione carboxamide inhibitors of endothelial lipase |
| 04/04/2013 | WO2013049096A1 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors |
| 04/04/2013 | WO2013048982A1 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors |
| 04/04/2013 | WO2013048949A2 Selective nr2b antagonists |
| 04/04/2013 | WO2013048942A1 Quinolinone carboxamide inhibitors of endothelial lipase |
| 04/04/2013 | WO2013048928A1 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors |
| 04/04/2013 | WO2013048916A1 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment |
| 04/04/2013 | WO2013047813A1 1,2,4-triazine-6-carboxamide derivative |
| 04/04/2013 | WO2013047750A1 Production methods for 3,4-dihydroisoquinoline derivatives, and production intermediates for same |
| 04/04/2013 | WO2013047749A1 Production method for 4, 4-difluoro-3,4-dihydroisoquinoline derivative |